🎁 Black Friday: up to 50% off of annual plans
Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
33.07
+1.30 (4.09%)
At close: Nov 20, 2026, 4:00 PM EST
33.30
+0.23 (0.70%)
After-hours: Nov 20, 2026, 7:30 PM EST

Lycia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
1,907--
Market Cap Growth
---
Enterprise Value
1,763--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.020.030.04
Net Debt / Equity Ratio
-1.00-0.99-1.09
Net Debt / EBITDA Ratio
4.412.294.35
Net Debt / FCF Ratio
4.291.724.43
Asset Turnover
-0.05-
Quick Ratio
12.2612.205.92
Current Ratio
12.6012.435.99
Return on Equity (ROE)
--34.17%-
Return on Assets (ROA)
-19.16%-29.39%-17.56%
Return on Capital Employed (ROCE)
-23.10%-44.00%-25.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
--5.22%-
SEC Filings: 10-K · 10-Q